Insider: KASINGER JAMES R. General Counsel and Secretary - CRISPR Therapeutics AG
| Company Holdings |
| Direct | Indirect Ownership | Total | |
| Shares | 94,308 | 0 | 94,308 |
| Value | $4,669,189.08 | $0.00 | $4,669,189.08 |
Trans. Date |
Trans. Type |
Shares |
Ownership Type |
Issue Type |
Price |
Trans. Value |
Total Shares Owned |
|---|---|---|---|---|---|---|---|
| 03/23/2026 | DDS | 3,182 | Direct | COM | $46.78 | $148,853.96 | 94,308 |
| 03/16/2026 | DDS | 3,450 | Direct | COM | $48.26 | $166,497.00 | 91,240 |
| 03/11/2026 | DDS | 2,800 | Direct | COM | $52.80 | $147,840.00 | 87,815 |
| 02/19/2026 | DDS | 2,112 | Direct | COM | $52.58 | $111,048.96 | 85,115 |
| 10/14/2025 | DDS | 1,076 | Direct | COM | $66.60 | $71,661.60 | 83,402 |
| 03/21/2025 | DDS | 3,185 | Direct | COM | $41.23 | $131,317.55 | 81,729 |
| 03/12/2025 | DDS | 1,116 | Direct | COM | $43.32 | $48,345.12 | 78,664 |
| 03/11/2025 | DDS | 2,850 | Direct | COM | $42.42 | $120,897.00 | 77,530 |
| 02/19/2025 | DDS | 1,947 | Direct | COM | $52.80 | $102,801.60 | 74,880 |
| 02/18/2025 | DDS | 9,595 | Direct | COM | $53.85 | $516,690.75 | 73,002 |
| 10/14/2024 | DDS | 1,089 | Direct | COM | $46.28 | $50,398.92 | 62,597 |
| 03/12/2024 | DDS | 1,146 | Direct | COM | $74.44 | $85,308.24 | 61,174 |
| 03/11/2024 | DDS | 2,801 | Direct | COM | $78.26 | $219,206.26 | 60,070 |
| 02/20/2024 | DDS | 1,913 | Direct | COM | $79.67 | $152,408.71 | 57,371 |
| 01/19/2021 | DDS | 6,785 | Direct | COM | $203.58 | $1,381,290.30 | 43,146 |
| 01/19/2021 | DDS | 7,818 | Direct | COM | $204.40 | $1,597,999.20 | 35,328 |
| 01/19/2021 | DDS | 2,100 | Direct | COM | $207.61 | $435,981.00 | 22,431 |
| 01/19/2021 | DDS | 1,800 | Direct | COM | $206.05 | $370,890.00 | 24,531 |
| 01/19/2021 | DDS | 8,997 | Direct | COM | $205.60 | $1,849,783.20 | 26,331 |
| 1 You are at page 1 of 1 pages |
|
Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust |
 |
Send to Excel |
© 2000 - 2026 Zacks Investment Research